GlassScriptPhysician profile
Tala M Kassm
NPI 1760800916
$4,289.64
in general payments reported to CMS, 2019-2025
10 companies · $962 in 2025
The $962 reported for 2025 was more than what 76% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $797 · 2020: $107 · 2022: $90.31 · 2023: $1,185 · 2024: $1,147 · 2025: $962.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,295.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,294.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| New World Medical,INC. | $1,199.46 | 2023-2024 | Streamline, Ahmed Glaucoma Valve, Kahook Dual Blade |
| Abbvie INC. | $1,193.74 | 2022-2025 | |
| Alcon Vision LLC | $639.28 | 2023-2025 | Hydrus Microstent, Clareon, Ngenuity |
| Alimera Sciences, INC. | $418.11 | 2019 | |
| Glaukos Corporation | $352.47 | 2024-2025 | Idose, Idosetr, Istent Infinite |
| Aerie Pharmaceuticals, INC. | $155.48 | 2019 | |
| Ocular Therapeutix, INC. | $113.00 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $110.72 | 2019 | |
| Allergan, INC. | $84.65 | 2020 | |
| Biotissue Holdings INC. | $22.73 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tala Kassm listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.